The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease (2015)
- Authors:
- Autor USP: GIORDANO, RICARDO JOSÉ - IQ
- Unidade: IQ
- DOI: 10.1126/scitranslmed.aac4882
- Subjects: DOENÇAS RETINIANAS; RECEPTORES
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2015
- Source:
- Título do periódico: Science Translational Medicine
- ISSN: 1946-6234
- Volume/Número/Paginação/Ano: v. 7, p. 1-15 art. 309, 2015
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
SIDMAN, Richard L et al. The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease. Science Translational Medicine, v. 7, p. 1-15 art. 309, 2015Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.aac4882. Acesso em: 04 maio 2024. -
APA
Sidman, R. L., Li, J., Lawrence, M., Hu, W., Musso, G. F., Giordano, R. J., et al. (2015). The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease. Science Translational Medicine, 7, 1-15 art. 309. doi:10.1126/scitranslmed.aac4882 -
NLM
Sidman RL, Li J, Lawrence M, Hu W, Musso GF, Giordano RJ, Cardó-Vila M, Pasqualini R, Arap W. The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease [Internet]. Science Translational Medicine. 2015 ; 7 1-15 art. 309.[citado 2024 maio 04 ] Available from: https://doi.org/10.1126/scitranslmed.aac4882 -
Vancouver
Sidman RL, Li J, Lawrence M, Hu W, Musso GF, Giordano RJ, Cardó-Vila M, Pasqualini R, Arap W. The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease [Internet]. Science Translational Medicine. 2015 ; 7 1-15 art. 309.[citado 2024 maio 04 ] Available from: https://doi.org/10.1126/scitranslmed.aac4882 - Estudos envolvendo uma família de glicoproteínas (Tc-85) da superfície do protozoário flagelado Trypanosoma cruzi
- Phage display and peptide-ligand maps in drug development: targeting the vascular endothelial growth factor pathway
- Searching for new anti-angiogenic compounds using phage display technology and a retinophaty model
- Vascular endothelial growth factor isoforms: cloning and expression in eukaryotic and procaryotic platforms
- The cerebral vascular diversity and identification of vascular targets capable of crossing the blood brain barrier
- Exploring with combinatorial approaches the molecular diversity of blood vessels in health and disease
- Molécula sintética pode inibir patologias em vasos sanguíneos [Depoimento a Karina Toledo]
- Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies
- Discovery of VEGF inhibitory peptides directed to extracellular ligand bindind domain of the VEGF receptors
- Development of a fab phage display system for the selection of antibodies with angiogenic properties
Informações sobre o DOI: 10.1126/scitranslmed.aac4882 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
